Donald Hoffman, MD
Neurology · Kingwood, WVNPI 1396772059
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,068 of the $1,217 with a category attached, or 87.8%. It is spread thinly across 17 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $653 and has fallen 71.0% since, to $190 in 2025. That places this record below the midpoint for neurology clinicians in WV, where the typical reported total is $1,217.
Across 60 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$235
- Lundbeck LLC$183
- Eisai Inc.$177
- Novartis$167
- Pfizer$105
- Tanabe Pharma America, Inc.$98
- plus $252 from 11 others
What the payments were for
- Food & beverage$1,06888%
- Education$14912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $235 |
| Lundbeck LLC | 11 | $183 |
| Eisai Inc. | 7 | $177 |
| Novartis | 8 | $167 |
| Pfizer | 6 | $105 |
| Tanabe Pharma America, Inc. | 4 | $98 |
| AbbVie(2 entities) | 3 | $51 |
| SK Life Science, Inc. | 1 | $33 |
| Medtronic | 1 | $26 |
| Bayer | 1 | $25 |
| Amgen | 2 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Baudax Bio Inc. | 1 | $17 |
| Neurelis, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$1,217 in reported general payments places this provider in the 50th percentile of 93 neurology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Avonex Pen (4 Pack)Interferon Beta-1a | 13 | $105,002 |
| CopaxoneGlatiramer Acetate | 12 | $83,999 |
| Teriflunomide | 17 | $75,610 |
| GlatopaGlatiramer Acetate | 12 | $29,520 |
| Emgality PenGalcanezumab-Gnlm | 39 | $26,719 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,869 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 162 | $4,007 |
| Baclofen | 32 | $2,896 |
| Levetiracetam | 60 | $2,547 |
| Oxcarbazepine | 24 | $1,568 |
| Gabapentin | 169 | $1,553 |
| Pyridostigmine Bromide | 18 | $1,123 |
| Lamotrigine | 45 | $1,083 |
| Duloxetine Hcl | 52 | $974 |
| Topiramate | 106 | $830 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Copaxone | $235 | $83,99912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 93 neurology providers in West Virginia.
Other neurology in Kingwood
- Barry VaughtCrab Orchard$1.4M
- Paul FergusonHuntington$649K
- Umer NajibMorgantown$246K
- Muhammed Nasher-AlneamCharleston$73K
- Robert LewisHurricane$73K
- Lauren SeebergerCharleston$72K
- Cheryl SmithMorgantown$68K
- Mouhannad AzzouzMorgantown$40K
- Gregory MathewsCharleston$30K
- Ronald BareboHuntington$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.